Whalesbook
Q4 Performance Driven by AI Deals
Mphasis reported strong fourth quarter fiscal year 2026 results, with revenue up 6% quarter-on-quarter in rupee terms (2.5% in constant currency). The positive analyst outlook stems from steady execution and a surge in AI-led deal wins. This momentum follows a fiscal year 2026 where total contract value (TCV) jumped 67.5% year-on-year, aided by better conversion rates. The company's pipeline has expanded 38%, driven mainly by the BFSI sector, with its NeoIPTM platform highlighting IP-led capabilities.
AI: Growth Driver and Deflation Risk
Choice Institutional Equities initiated coverage with a 'BUY' rating and a ₹2,625 target price. The firm forecasts revenue, EBIT, and PAT to grow at a compound annual growth rate (CAGR) of 12.2%, 14.3%, and 14.2% from FY26 to FY29. This outlook is based on Mphasis's strong position in the AI adoption cycle, with AI-led deals making up 69% of its pipeline. However, this growth faces sector-wide headwinds. Indian IT companies are increasingly seeing the risk of 'AI deflation,' where AI automation may lead to a 2-3% annual decrease in traditional IT services revenue. Peers acknowledge this; TCS’s CEO mentioned 'degrowth' in some areas due to AI, and Infosys and HCLTech CEOs expect it to be a factor. While Mphasis's Q4 FY26 growth was strong, this deflationary pressure could limit future revenue growth and affect margins.
Premium Valuation and Past Performance
Mphasis currently trades at a premium valuation, with a Trailing Twelve Months (TTM) P/E ratio near 23.5x, exceeding the IT sector average of about 21x. This P/E is higher than large rivals like TCS (17.9x-32x) and Infosys (16.6x-29x). Historically, Mphasis's performance has been mixed. Over the last five years, its earnings growth (6.5%) and revenue growth (7.3%) have lagged the IT industry's average growth rates (25.3% for earnings, 11.06% for revenue). Despite strong Q4 FY26 results, its market share has declined over this period. While most analysts keep 'Outperform' or 'Buy' ratings, price targets show significant dispersion, ranging from ₹2,193 to ₹3,410, indicating diverse analyst views on future performance.
Analyst Concerns on Competition and Execution
Key risks remain despite positive analyst ratings and AI growth potential. Mphasis operates in a competitive market where larger IT players like TCS and Infosys have more scale and broader service offerings, and are also investing heavily in AI. The company's historical financial growth has lagged industry averages, raising concerns about its ability to gain market share long-term. Its current valuation premium requires strong, consistent execution to justify. Moreover, reliance on AI deals exposes Mphasis to 'AI deflation' risks. If AI significantly reduces the need for traditional services, it could lead to industry-wide pricing pressure, impacting companies like Mphasis more severely as they compete with giants. The wide range in analyst price targets reflects this uncertainty and differing market views.
Navigating Future Growth
Analysts project Mphasis will achieve revenue, EBIT, and PAT CAGRs of 12.2%, 14.3%, and 14.2% from FY26 to FY29. The analyst consensus is largely positive, with most maintaining 'Outperform' or 'Buy' ratings. Success will depend on Mphasis balancing its premium valuation with the impact of AI deflation and intense competition. Its strategic focus on AI and the NeoIPTM platform will be key differentiators for future growth in the evolving tech spending landscape.